These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18097556)

  • 1. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2007 Mar; 30(3):695-700. PubMed ID: 17273771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin associates with cell proliferation in renal cancer cells: regulation of survivin expression by insulin-like growth factor-1, interferon-gamma and a novel NF-kappaB inhibitor.
    Sato A; Oya M; Ito K; Mizuno R; Horiguchi Y; Umezawa K; Hayakawa M; Murai M
    Int J Oncol; 2006 Apr; 28(4):841-6. PubMed ID: 16525632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
    Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
    Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
    Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential novel combination therapy targeting survivin in renal cancer cells: Inhibition of survivin expression by topotecan and hexamethylene bisacetamide.
    Sato A; Asano T; Ito K; Sumitomo M; Asano T; Hayakawa M
    Mol Med Rep; 2009; 2(3):423-8. PubMed ID: 21475845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
    Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells.
    Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Watanabe N
    Anticancer Res; 2005; 25(6B):3967-72. PubMed ID: 16309185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
    Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
    Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
    Chen T; Deng C
    Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
    Chao JI; Liu HF
    Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing survivin gene expression promotes apoptosis of human breast cancer cells through a caspase-independent pathway.
    Croci DO; Cogno IS; Vittar NB; Salvatierra E; Trajtenberg F; Podhajcer OL; Osinaga E; Rabinovich GA; Rivarola VA
    J Cell Biochem; 2008 Oct; 105(2):381-90. PubMed ID: 18553460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
    Kappler M; Bache M; Bartel F; Kotzsch M; Panian M; Würl P; Blümke K; Schmidt H; Meye A; Taubert H
    Cancer Gene Ther; 2004 Mar; 11(3):186-93. PubMed ID: 14739938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
    Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
    Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
    Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.